(Reuters) - The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic infections, the company said on Monday. The drug, branded as ...
Medtronic (NYSE:MDT) today announced a voluntary recall warning of battery issues with its MiniMed 600 and 700 series insulin pumps. FDA deemed the recall Class I, the most serious kind. The medtech ...
DSM-Firmenich says the FDA is expected to decide within the next 17.5 months — by March 2026 — on the company's request to approve the sunscreen ingredient bemotrizinol, branded as PARSOL Shield.
In September, the U.S. Food and Drug Administration approved Apple's Hearing Aid Feature (HAF). It is the first over-the-counter hearing aid software that can be used with a version of the AirPods Pro ...
The U.S. Food and Drug Administration (FDA) recently approved the first two drugs to treat the rare lysosomal storage disorder Niemann-Pick disease type C. Both of these drugs were given the green ...
The deal has paid off as Karuna’s lead asset was approved last week by the US FDA. Cobenfy is a combination of xanomeline, which acts on the muscarinic receptor system by activating it and trospium, ...
The US Food and Drug Administration has approved dupilumab as an add-on maintenance therapy for adults whose chronic obstructive pulmonary disease (COPD) is inadequately controlled with inhaler ...
"As the drug has already been approved, it doesn't have to undergo a complex approval procedure and could soon supplement the standard therapy for this deadly brain tumor." A noninvasive treatment ...
By Thanksgiving, the Food and Drug Administration is expected to decide on approval of BridgeBio's acoramidis, likely kicking off a new phase in the debate. The agency is also set to reach verdicts ...
The U.S. Food and Drug Administration (FDA) recently approved a nasal spray flu vaccine, called FluMist, for people ages 2 to 49 that can be ordered from an online pharmacy and administered at home.
The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...